CancerCare Manitoba
In research, CancerCare Manitoba stands highest in Medicine (#4,400 of 10,443 worldwide) and Health Sciences (#5,831 of 11,982 worldwide), 2022–2025. Relative to its size it is most specialised in Oncology — Oncology is 12.9× its share of world research.
- World rank, 2022–2025
- #10,291 of 28,054 · #8,872 all time
- Rank in Canada
- #175 of 403
- Research works
- 1.1k ▼ 6% vs 2013–17
- Citations
- 32k 28.4 per fractional work
- Top-10% rate
- 20.3% record average 16.5%
- Open access
- 42% world 28%
What is CancerCare Manitoba known for in research?
The fields where it stands highest, 2022–2025, ranked among every institution above the floor in each field.
| Field | World rank | Where that sits | Top-10% rate | Works | All time |
|---|---|---|---|---|---|
| MedicineField | #4,400 of 10,443 | 19.4% | 120 | #3160 | |
| Health SciencesDomain | #5,831 of 11,982 | 19.3% | 127 | #3937 |
Each strip is that field’s whole ranked pool, with the notch where CancerCare Manitoba sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no world mark, because the world rate differs by field (from about 6% to 21% in this record).
What does CancerCare Manitoba specialise in?
Where its research is concentrated relative to its size: Oncology takes 12.9× the share of its output that it takes of world research.
- OncologySubfield · 27.2 works13×
Location quotient, a volume reading rather than an impact one. It surfaces small, lopsided specialities.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Medicine, 3.3×. Every wedge is a field page.
- Medicine 3.3×
- Biochemistry, Genetics and Molecular Biology 3.0×
- Immunology and Microbiology 1.9×
- Health Professions 1.3×
- Physics and Astronomy 1.0×
- Psychology 0.8×
- Chemistry 0.6×
- Nursing 0.6×
- Pharmacology, Toxicology and Pharmaceutics 0.5×
- Economics, Econometrics and Finance 0.5×
- Neuroscience 0.5×
- Engineering 0.2×
- Computer Science 0.1×
- Materials Science 0.1×
- Dentistry 0.1×
- Social Sciences 0.1×
- Mathematics 0.1×
- Arts and Humanities 0.1×
- Agricultural and Biological Sciences 0.1×
- Business, Management and Accounting 0.0×
- Environmental Science 0.0×
- Decision Sciences 0.0×
Who are the top researchers at CancerCare Manitoba?
Ranked on the composite score, Marshall Pitz, Erich V. Kliewer and Geoff D.E. Cuvelier lead among researchers whose main affiliation is CancerCare Manitoba.
- 1 Marshall Pitz Canada · #147,757 worldwide 153 citations · 22 works
- 2 Erich V. Kliewer Canada · #434,273 worldwide 98 citations · 19 works
- 3 Geoff D.E. Cuvelier Canada · #465,072 worldwide 66 citations · 16 works
- 4 Richard W. Nason Canada · #525,418 worldwide 20 citations · 21 works
- 5 Alain Demers Canada · #590,725 worldwide 95 citations · 17 works
- 6 Pascal Lambert Canada · #663,693 worldwide 44 citations · 32 works
- 7 Oliver Bucher Canada · #838,657 worldwide 24 citations · 17 works
- 8 Piotr Czaykowski Canada · #975,680 worldwide 32 citations · 17 works
- 9 Anne Katz Canada · #991,694 worldwide 29 citations · 36 works
- 10 Arbind Dubey Canada · #1,023,395 worldwide 13 citations · 21 works
Which keywords describe research at CancerCare Manitoba?
By fractional works in 2022–2025, weighted toward what it does more of than the world: Chemotherapy, Cancer, Clinical Trials, Prognostic Factors, Immunotherapy, Radiotherapy, Clinical Practice Guidelines and Targeted Therapy.
- Advance Care Planning
- Cancer Risk
- Radiotherapy Physics
- Image-Guided Radiotherapy
- Neoadjuvant Therapy
- Genomic Profiling
- Surgery
- Tumor Markers
- Ethical Considerations
- Health-related Quality of Life
- Cancer Incidence
- Cancer Therapy
- Mortality
- End-of-Life
- Metastasis
- Targeted Therapy
- Radiotherapy
- Quality of Life
- Prognostic Factors
- Cancer
- Chemotherapy
- Clinical Trials
- Immunotherapy
- Epidemiology
- Clinical Practice Guidelines
- Biomarkers
- Palliative Care
- Risk Factors
- Tumor Microenvironment
- Anxiety
- Precision Medicine
- Rituximab
- Dosimetry
- Molecular Characterization
- Breast Cancer
- Survival Analysis
- Cancer Survivorship
- Molecular Classification
- Adjuvant Therapy
- Health Care Costs
Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Chemotherapy18▲ 14×22 topics
- Cancer15▲ 6.0×35 topics
- Clinical Trials13▲ 10×13 topics
- Prognostic Factors13▲ 15×13 topics
- Immunotherapy12▲ 8.7×15 topics
- Quality of Life11▲ 4.0×20 topics
- Epidemiology9▲ 1.26×49 topics
- Radiotherapy9▲ 13×11 topics
- Clinical Practice Guidelines8▲ 8.3×13 topics
- Targeted Therapy8▲ 20×4 topics
- Biomarkers8▲ 6.2×12 topics
- Metastasis8▲ 12×10 topics
- Palliative Care6▲ 21×4 topics
- End-of-Life6▲ 36×3 topics
- Risk Factors6▲ 2.9×11 topics
- Mortality6▲ 5.2×7 topics
- Tumor Microenvironment6▲ 6.6×7 topics
- Cancer Therapy5▲ 4.5×14 topics
- Anxiety5▲ 5.4×6 topics
- Cancer Incidence5▲ 19×4 topics
- Precision Medicine5▲ 5.5×7 topics
- Health-related Quality of Life5▲ 11×4 topics
- Rituximab5▲ 17×3 topics
- Ethical Considerations5▲ 7.2×7 topics
- Dosimetry4▲ 33×2 topics
- Tumor Markers4▲ 28×2 topics
- Molecular Characterization4▲ 12×5 topics
- Surgery4▲ 6.2×6 topics
- Breast Cancer4▲ 8.8×10 topics
- Genomic Profiling4▲ 20×2 topics
- Survival Analysis4▲ 7.7×5 topics
- Neoadjuvant Therapy4▲ 8.4×5 topics
- Cancer Survivorship4▲ 26×2 topics
- Image-Guided Radiotherapy4▲ 46×1 topic
- Molecular Classification4▲ 13×2 topics
- Radiotherapy Physics4▲ 46×1 topic
- Adjuvant Therapy4▲ 15×2 topics
- Cancer Risk4▲ 8.4×7 topics
- Health Care Costs4▲ 23×2 topics
- Advance Care Planning3▲ 31×1 topic
Which research topics does CancerCare Manitoba publish most on?
By volume in 2022–2025: Advanced Radiotherapy Techniques, Palliative Care and End-of-Life Issues, Lung Cancer Treatments and Mutations and COVID-19 and healthcare impacts.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Advanced Radiotherapy Techniques Radiation 4 works
- 2 Palliative Care and End-of-Life Issues Public Health, Environmental and Occupational Health 3 works
- 3 Lung Cancer Treatments and Mutations Pulmonary and Respiratory Medicine 3 works
- 4 COVID-19 and healthcare impacts Oncology 3 works
- 5 Lung Cancer Research Studies Oncology 3 works
- 6 Cancer survivorship and care Oncology 3 works
- 7 Chronic Lymphocytic Leukemia Research Genetics 3 works
- 8 Global Cancer Incidence and Screening Oncology 3 works
- 9 Patient Dignity and Privacy Public Health, Environmental and Occupational Health 3 works
- 10 Lung Cancer Diagnosis and Treatment Pulmonary and Respiratory Medicine 2 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has CancerCare Manitoba's research output changed?
Output in 2018–2022 was 6% lower than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Winnipeg
- University of Manitoba
- Health Sciences Centre
- University of Winnipeg
- St. Boniface Hospital
- Research Manitoba
- Agriculture Food and Rural Development
- Manitoba Health
- Children's Hospital Research Institute of Manitoba
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.